A.L. Johnson

4.9k total citations · 2 hit papers
62 papers, 4.2k citations indexed

About

A.L. Johnson is a scholar working on Molecular Biology, Organic Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, A.L. Johnson has authored 62 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 32 papers in Organic Chemistry and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A.L. Johnson's work include Receptor Mechanisms and Signaling (16 papers), Synthesis and Reactions of Organic Compounds (14 papers) and Renin-Angiotensin System Studies (10 papers). A.L. Johnson is often cited by papers focused on Receptor Mechanisms and Signaling (16 papers), Synthesis and Reactions of Organic Compounds (14 papers) and Renin-Angiotensin System Studies (10 papers). A.L. Johnson collaborates with scholars based in United States, China and Canada. A.L. Johnson's co-authors include Andrew T. Chiu, David J. Carini, John V. Duncia, Pancras C. Wong, William A. Price, Ruth R. Wexler, Pieter B.M.W.M. Timmermans, Dale E. McCall, Gregory J. Wells and William F. Herblin and has published in prestigious journals such as Journal of the American Chemical Society, Biochemical and Biophysical Research Communications and Hypertension.

In The Last Decade

A.L. Johnson

61 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of angiotensin II receptor subtypes

1989 705 citations Andrew T. Chiu, William F. Herblin et al. profile →
Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives

1991 369 citations David J. Carini, John V. Duncia et al. Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A.L. Johnson United States	29	2.2k	2.1k	1.1k	984	578	62	4.2k
John V. Duncia United States	29	2.3k 1.1×	2.1k 1.0×	1.1k 1.1×	949 1.0×	568 1.0×	52	4.2k
David J. Carini United States	35	3.6k 1.6×	2.9k 1.4×	1.7k 1.6×	1.1k 1.2×	722 1.2×	51	6.0k
Wolfgang Wienen Germany	28	2.3k 1.0×	1.1k 0.5×	424 0.4×	408 0.4×	810 1.4×	48	4.2k
Ruth R. Wexler United States	43	4.5k 2.1×	3.5k 1.7×	1.7k 1.6×	2.0k 2.0×	735 1.3×	180	8.9k
Andrew T. Chiu United States	42	5.4k 2.4×	4.3k 2.1×	2.5k 2.3×	770 0.8×	1.2k 2.0×	89	8.0k
Pancras C. Wong United States	46	6.6k 3.0×	4.0k 1.9×	2.3k 2.2×	1.2k 1.2×	979 1.7×	156	10.2k
William J. Greenlee United States	34	693 0.3×	2.2k 1.1×	227 0.2×	2.0k 2.0×	642 1.1×	161	4.5k
Claire Lugnier France	42	1.2k 0.5×	4.0k 1.9×	234 0.2×	983 1.0×	524 0.9×	148	5.9k
Amedeo Leonardi Italy	28	301 0.1×	960 0.5×	287 0.3×	525 0.5×	537 0.9×	95	2.1k
Dale E. Mais United States	32	287 0.1×	1.9k 0.9×	386 0.4×	554 0.6×	412 0.7×	107	3.9k

Countries citing papers authored by A.L. Johnson

Since Specialization

Citations

This map shows the geographic impact of A.L. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.L. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.L. Johnson more than expected).

Fields of papers citing papers by A.L. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.L. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.L. Johnson. The network helps show where A.L. Johnson may publish in the future.

Co-authorship network of co-authors of A.L. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of A.L. Johnson. A scholar is included among the top collaborators of A.L. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.L. Johnson. A.L. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wityak, John, John M. Fevig, Sharon Jackson, et al.. (1995). Synthesis and antiplatelet activity of DMP 757 analogs. Bioorganic & Medicinal Chemistry Letters. 5(18). 2097–2100. 11 indexed citations

Higley, C. Anne, Richard G. Wilde, Thomas Maduskuie, et al.. (1994). Acyl CoA:Cholesterol Acyltransferase (ACAT) Inhibitors: Synthesis and Structure-Activity Relationship Studies of a New Series of Trisubstituted Imidazoles. Journal of Medicinal Chemistry. 37(21). 3511–3522. 28 indexed citations

Wong, Pancras C., Paul E. Aldrich, Andrew T. Chiu, et al.. (1993). Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic.. Journal of Pharmacology and Experimental Therapeutics. 265(3). 1088–1095. 2 indexed citations

Cain, Gary A., Thomas E. Christos, A.L. Johnson, et al.. (1993). Neurotensin receptor binding and antinociceptive activity for lipophilic Nα-amido neurotensin(9–13) analogs. Bioorganic & Medicinal Chemistry Letters. 3(10). 2055–2060. 6 indexed citations

Duncia, John V., David J. Carini, Andrew T. Chiu, et al.. (1992). The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonist. Medicinal Research Reviews. 12(2). 149–191. 173 indexed citations

Chiu, Andrew T., Dale E. McCall, William A. Price, et al.. (1991). In Vitro Pharmacology of DuP 753. American Journal of Hypertension. 4(4_Pt_2). 282S–287S. 44 indexed citations

Wong, Pancras C., William A. Price, Andrew T. Chiu, et al.. (1991). In Vivo Pharmacology of DuP 753. American Journal of Hypertension. 4(4_Pt_2). 288S–298S. 99 indexed citations

Timmermans, P.B.M.W.M., David J. Carini, Andrew T. Chiu, et al.. (1991). Angiotensin II receptor antagonists. From discovery to antihypertensive drugs.. Hypertension. 18(5_supplement). III136–42. 64 indexed citations

Herblin, William F., Andrew T. Chiu, Dale E. McCall, et al.. (1991). Angiotensin II Receptor Heterogeneity. American Journal of Hypertension. 4(4_Pt_2). 299S–302S. 50 indexed citations

10.

Timmermans, Pieter B.M.W.M., David J. Carini, Andrew T. Chiu, et al.. (1991). The Discovery of a New Class of Highly Specific Nonpeptide Angiotensin II Receptor Antagonists. American Journal of Hypertension. 4(4_Pt_2). 275S–281S. 46 indexed citations

11.

Timmermans, Pieter B.M.W.M., David J. Carini, Andrew T. Chiu, et al.. (1990). Nonpeptide Angiotensin II Receptor Antagonists. American Journal of Hypertension. 3(8_Pt_1). 599–604. 51 indexed citations

12.

Chiu, Andrew T., Dale E. McCall, William A. Price, et al.. (1990). Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.. Journal of Pharmacology and Experimental Therapeutics. 252(2). 711–718. 284 indexed citations

13.

Wong, Pancras C., William A. Price, Andrew T. Chiu, et al.. (1990). Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.. Journal of Pharmacology and Experimental Therapeutics. 255(1). 211–217. 292 indexed citations

14.

Carini, David J., John V. Duncia, A.L. Johnson, et al.. (1990). Part VI. Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensives. Journal of Medicinal Chemistry. 33(5). 1330–1336. 65 indexed citations

15.

Duncia, John V., Andrew T. Chiu, David J. Carini, et al.. (1990). The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives. Journal of Medicinal Chemistry. 33(5). 1312–1329. 187 indexed citations

16.

Wong, Pancras C., William A. Price, Andrew T. Chiu, et al.. (1989). Nonpeptide angiotensin II receptor antagonists. IV. EXP6155 and EXP6803.. Hypertension. 13(5). 489–497. 43 indexed citations

17.

Chiu, Andrew T., David J. Carini, A.L. Johnson, et al.. (1988). Non-peptide angiotensin II receptor antagonists. II . Pharmacology of S-8308. European Journal of Pharmacology. 157(1). 13–21. 63 indexed citations

18.

CHENARD, B. L., et al.. (1985). Synthesis, structure, and properties of pentathiepins. Journal of the American Chemical Society. 107(13). 3871–3879. 114 indexed citations

19.

Johnson, A.L. & H. E. Simmons. (1966). 13,14-Diazatricyclo[6.4.1.1^2,7]tetradeca-3,5,9,11-tetraene and Its Derivatives. Journal of the American Chemical Society. 88(11). 2591–2593. 10 indexed citations

20.

Johnson, A.L., et al.. (1963). The Chemistry of Actinamine¹. The Journal of Organic Chemistry. 28(2). 300–304. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact